A Prospective and Randomized Comparison of Ultrasound-guided Transversus Abdominis Plane Versus Rectus Sheath Blocks as a Primary Anesthetic for Abdominal Wall Surgery in Adults.
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 15
- 试验地点
- 2
- 主要终点
- Changes between the two groups to provide surgical anesthesia
研究概览
简要总结
Compare the ability of the transversus abdominis plane block (TAPB) and rectus sheath block (RSB) to provide surgical anesthesia for overweight and obese patients undergoing umbilical hernia surgery.
详细描述
The purpose of this research study is to compare the ability of the TAPB and RSB to provide anesthesia for overweight and obese patients undergoing abdominal wall surgery. At the present time, this procedure is performed under general anesthesia, which often poses increased risks for overweight and obese individuals. It is not known if these blocks could be used to avoid the use of general anesthesia.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Treatment
- 盲法
- None
入排标准
- 年龄范围
- 18 Years 至 99 Years（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Patients ≥ 18 years of age undergoing umbilical hernia repair
- •Overweight and obese individuals (defined as a body mass index of ≥ 25 and 30 kg/m2, respectively)
- •Ability to understand and provide informed consent
排除标准
- •Patient refusal or inability to provide informed consent
- •True allergy, not sensitivity, local anesthetics
- •True allergy, not sensitivity, Propofol
- •True allergy, not sensitivity, general anesthetic agents
- •Pregnancy
- •Severe hepatic impairment
- •Evidence of infection at or near the proposed needle insertion site
- •Any sensorimotor deficit, whether acute or chronic, as determined by the PI
- •Chronic use of opioid medication
结局指标
主要结局
Changes between the two groups to provide surgical anesthesia
时间窗: Changes from baseline (pre-op) to 1 hour post-operative
Assessed by the ability of the TAPB and RSB to provide primary surgical anesthesia
次要结局
- Changes between the two groups assessed by post-operative pain control(Changes from baseline (post-operative) to 48 hours post-operative)